{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:19:52Z","timestamp":1779916792888,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14946-8","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:46:16Z","timestamp":1759315576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting GSTM3 for therapeutic potential in advanced prostate cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Didem","family":"Seven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altay Burak","family":"Dalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer Faruk","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"14946_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of Pmtmptate cancer. World J Oncol. 2019;10:63.","journal-title":"World J Oncol"},{"key":"14946_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41416-022-02136-3","volume":"128","author":"J Lin","year":"2023","unstructured":"Lin J, Nousome D, Jiang J, et al. Five-year survival of patients with late-stage prostate cancer: comparison of the military health system and the US general population. Br J Cancer. 2023;128:1070\u20136.","journal-title":"Br J Cancer"},{"key":"14946_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.12.001","author":"A Cruz-Lebr\u00f3n","year":"2025","unstructured":"Cruz-Lebr\u00f3n A, Faiez TS, Hess MM, Sfanos KS. Diet and the microbiome as mediators of prostate cancer risk, progression, and therapy response. Urol Oncol Semin Orig Investig. 2025. https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.001.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"1","key":"14946_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1158\/1078-0432.CCR-24-2483","volume":"31","author":"KH Stopsack","year":"2025","unstructured":"Stopsack KH, Vijai J, Conry M, et al. Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer. Clin Cancer Res. 2025;31(1):122\u20139.","journal-title":"Clin Cancer Res"},{"key":"14946_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5694\/mja2.51722","volume":"217","author":"IS Williams","year":"2022","unstructured":"Williams IS, McVey A, Perera S, et al. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022;217:424\u201333. https:\/\/doi.org\/10.5694\/mja2.51722.","journal-title":"Med J Aust"},{"key":"14946_CR6","doi-asserted-by":"publisher","unstructured":"Sandhu S, Moore CM, Chiong E et al. SG Williams Prostate cancer. 2021;398. https:\/\/doi.org\/10.1016\/S0140-6736(21)00950-8.","DOI":"10.1016\/S0140-6736(21)00950-8"},{"key":"14946_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/pcan.2016.30","volume":"19","author":"AB Weiner","year":"2016","unstructured":"Weiner AB, Matulewicz RS, Eggener SE, Schaeffer EM. Increasing incidence of metastatic prostate cancer in the united States (2004\u20132013). Prostate Cancer Prostatic Dis. 2016;19:395\u20137.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"14946_CR8","doi-asserted-by":"publisher","first-page":"103327","DOI":"10.1016\/j.critrevonc.2021.103327","volume":"162","author":"N Devarajan","year":"2021","unstructured":"Devarajan N. Tumor hypoxia: the major culprit behind cisplatin resistance in cancer patients. Crit Rev Oncol-Hematol. 2021;162:103327.","journal-title":"Crit Rev Oncol-Hematol"},{"key":"14946_CR9","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.3390\/cancers15235615","volume":"15","author":"S Wasim","year":"2023","unstructured":"Wasim S, Park J, Nam S, Kim J. Review of current treatment intensification strategies for prostate cancer patients. Cancers. 2023;15:5615.","journal-title":"Cancers"},{"key":"14946_CR10","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, et al. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27:5730.","journal-title":"Molecules"},{"key":"14946_CR11","doi-asserted-by":"crossref","unstructured":"Li D, Gao Q, Xu L, Pang S, Liu Z, Wang C et al. Characterization of glutathione S-transferases in the detoxification of metolachlor in two maize cultivars of differing herbicide tolerance. Pestic Biochem Physiol. 2017;143:265-71.","DOI":"10.1016\/j.pestbp.2016.12.003"},{"key":"14946_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/annonc\/mdw646","volume":"28","author":"M Shiota","year":"2017","unstructured":"Shiota M, Fujimoto N, Itsumi M, et al. Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress. Ann Oncol. 2017;28:569\u201375.","journal-title":"Ann Oncol"},{"key":"14946_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13000-021-01069-4","volume":"16","author":"F Yang","year":"2021","unstructured":"Yang F, Wen J, Luo K, Fu J. Low GSTM3 expression is associated with poor disease-free survival in resected esophageal squamous cell carcinoma. Diagn Pathol. 2021;16:10. https:\/\/doi.org\/10.1186\/s13000-021-01069-4.","journal-title":"Diagn Pathol"},{"key":"14946_CR14","doi-asserted-by":"publisher","first-page":"10377","DOI":"10.2147\/CMAR.S272467","volume":"12","author":"S Wang","year":"2020","unstructured":"Wang S, Yang J, You L, et al. GSTM3 function and polymorphism in cancer: emerging but promising. CMAR Volume. 2020;12:10377\u201388. https:\/\/doi.org\/10.2147\/CMAR.S272467.","journal-title":"CMAR Volume"},{"key":"14946_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, et al. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70:299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613.","journal-title":"CA Cancer J Clin"},{"key":"14946_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/path.4021","volume":"228","author":"S Meding","year":"2012","unstructured":"Meding S, Balluff B, Elsner M, et al. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. J Pathol. 2012;228:459\u201370. https:\/\/doi.org\/10.1002\/path.4021.","journal-title":"J Pathol"},{"key":"14946_CR17","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1200\/JCO.2008.18.5744","volume":"27","author":"AP Mitra","year":"2009","unstructured":"Mitra AP, Pagliarulo V, Yang D, et al. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. JCO. 2009;27:3929\u201337. https:\/\/doi.org\/10.1200\/JCO.2008.18.5744.","journal-title":"JCO"},{"key":"14946_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10549-018-4897-5","volume":"172","author":"J-H Lin","year":"2018","unstructured":"Lin J-H, Tu S-H, Chen L-C, et al. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells. Breast Cancer Res Treat. 2018;172:45\u201359.","journal-title":"Breast Cancer Res Treat"},{"key":"14946_CR19","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3748\/wjg.v17.i13.1772","volume":"17","author":"Y-S Li","year":"2011","unstructured":"Li Y-S, Liu M, Nakata Y, Tang H-B. \u03b2-catenin accumulation in nuclei of hepatocellular carcinoma cells up-regulates glutathione-s-transferase M3 mRNA. World J Gastroenterology: WJG. 2011;17:1772.","journal-title":"World J Gastroenterology: WJG"},{"key":"14946_CR20","doi-asserted-by":"publisher","first-page":"1079037","DOI":"10.3389\/fonc.2023.1079037","volume":"13","author":"C Stevens","year":"2023","unstructured":"Stevens C, Hightower A, Buxbaum SG, et al. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. Front Oncol. 2023;13:1079037.","journal-title":"Front Oncol"},{"key":"14946_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12859-021-04130-7","volume":"22","author":"HE Miller","year":"2021","unstructured":"Miller HE, Bishop AJR. Correlation analyzer: functional predictions from gene co-expression correlations. BMC Bioinformatics. 2021;22:206. https:\/\/doi.org\/10.1186\/s12859-021-04130-7.","journal-title":"BMC Bioinformatics"},{"key":"14946_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s42003-021-02140-y","volume":"4","author":"W Rayford","year":"2021","unstructured":"Rayford W, Beksac AT, Alger J, et al. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. Commun Biol. 2021;4:670.","journal-title":"Commun Biol"},{"key":"14946_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/scd.2013.0157","volume":"23","author":"RM Rodrigues","year":"2014","unstructured":"Rodrigues RM, De Kock J, Branson S, et al. Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals. Stem Cells Dev. 2014;23:44\u201355. https:\/\/doi.org\/10.1089\/scd.2013.0157.","journal-title":"Stem Cells Dev"},{"key":"14946_CR24","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.3390\/ijms22137080","volume":"22","author":"S-Y Cheng","year":"2021","unstructured":"Cheng S-Y, Chen N-F, Wen Z-H, et al. Glutathione S-transferase M3 is associated with Glycolysis in intrinsic temozolomide-resistant glioblastoma multiforme cells. Int J Mol Sci. 2021;22:7080.","journal-title":"Int J Mol Sci"},{"key":"14946_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155752","author":"Z Kang","year":"2024","unstructured":"Kang Z, Wang P, Wang B, et al. Echinatin suppresses cutaneous squamous cell carcinoma by targeting GSTM3-mediated ferroptosis. Phytomedicine. 2024. https:\/\/doi.org\/10.1016\/j.phymed.2024.155752.","journal-title":"Phytomedicine"},{"key":"14946_CR26","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-07-5259","volume":"68","author":"B Kumar","year":"2008","unstructured":"Kumar B, Koul S, Khandrika L, et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008;68:1777\u201385.","journal-title":"Cancer Res"},{"key":"14946_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mrfmmm.2012.03.003","volume":"736","author":"M Dusinska","year":"2012","unstructured":"Dusinska M, Staruchova M, Horska A, et al. Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Mutat Res-Fund Mol Mech Mutagen. 2012;736:130\u20137.","journal-title":"Mutat Res-Fund Mol Mech Mutagen"},{"key":"14946_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s11060-019-03185-0","volume":"143","author":"G Li","year":"2019","unstructured":"Li G, Cai Y, Wang C, et al. LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells. J Neurooncol. 2019;143:525\u201336.","journal-title":"J Neurooncol"},{"key":"14946_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41416-024-02574-1","volume":"130","author":"Y Chen","year":"2024","unstructured":"Chen Y, Feng Y, Lin Y, et al. GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14\/FASN axis and GPX4. Br J Cancer. 2024;130:755\u201368.","journal-title":"Br J Cancer"},{"key":"14946_CR30","doi-asserted-by":"publisher","first-page":"215692","DOI":"10.1016\/j.canlet.2022.215692","volume":"538","author":"T Chen","year":"2022","unstructured":"Chen T, Jinlin D, Wang F, et al. GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1\/NRF2-KEAP1 signaling. Cancer Letters. 2022;538:215692.","journal-title":"Cancer Lett"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14946-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:46:17Z","timestamp":1759315577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14946-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14946"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14946-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized commercially available cell lines; therefore, no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1493"}}